Abstract Number: 358 • ACR/ARP Annual Meeting 2019
Emergency Department Encounters in a Large US Payer Database: Tophaceous versus Non-tophaceous Gout Patients
Background/Purpose: From 2006 to 2012, gout was the primary indication for ~0.2% of all emergency department visits for adults, as reported in the Nationwide Emergency…Abstract Number: 1264 • ACR/ARHP Annual Meeting 2018
Modeling the Costs and Outcomes Associated with Treatment Sequences, with and without Tofacitinib, for Moderately to Severely Active Psoriatic Arthritis in the US
Background/Purpose: Psoriatic Arthritis (PsA) is a chronic progressive inflammatory condition associated with significant direct and indirect costs. Tofacitinib is an oral Janus kinase inhibitor for…Abstract Number: 2277 • ACR/ARHP Annual Meeting 2014
Inpatient Pediatric Rheumatic Diseases: Characteristics, Cost and Trends
Background/Purpose: Childhood rheumatic diseases (cRD) have wide spectrum of complexity and disease course from mild disease to acute fulminate disease and even sudden death. Physicians…
ACR Meeting Abstracts